Cargando…
Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice
The spike (S) protein is a leading vaccine candidate against SARS-CoV-2 infection. The S1 domain of S protein, which contains a critical receptor-binding domain (RBD) antigen, potentially induces protective immunoreactivities against SARS-CoV-2. In this study, we presented preclinical evaluations of...
Autores principales: | Lin, Hui-Tsu, Chen, Cheng-Cheung, Chiao, Der-Jiang, Chang, Tein-Yao, Chen, Xin-An, Young, Jenn-Jong, Kuo, Szu-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580573/ https://www.ncbi.nlm.nih.gov/pubmed/34774590 http://dx.doi.org/10.1016/j.ijbiomac.2021.11.020 |
Ejemplares similares
-
CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015) -
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
por: Li, Yibo, et al.
Publicado: (2023) -
Modeling of Nanoparticular Magnetoresistive Systems and the Impact on Molecular Recognition
por: Teich, Lisa, et al.
Publicado: (2015) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
por: Lin, Yu-Li, et al.
Publicado: (2018)